Podcast Summary: Full Measure After Hours

Episode: America’s Drug Price Disaster
Host: Sharyl Attkisson
Guest: Jack Hoadley, Research Professor Emeritus, Georgetown University
Date: March 5, 2026

Overview

In this episode, Sharyl Attkisson explores the complex and often opaque world of American prescription drug pricing. Joined by health policy expert Dr. Jack Hoadley, she breaks down why drug prices have skyrocketed since the Affordable Care Act, uncovers the hidden mechanics behind insurance and pharmacy deals, and discusses what consumers can actually do to lower the cost of their prescriptions. The conversation aims to clarify the system’s many layers and offer practical advice amid the confusion and frustration experienced by countless Americans.

Key Discussion Points & Insights

1. The Perplexing Nature of Drug Pricing

• Complexity and Artificiality:
  • Drug pricing in the U.S. is described as "a very complicated system and...artificial" (03:02). Most people do not pay the actual cost of the drug; instead, they pay a copay through insurance, which hides the real price.
  • List prices—like “average wholesale price” (AWP)—are explained as “not something that really anybody pays” (03:02). In Hoadley’s words:

    “There’s a concept called average wholesale price… but sometimes people say it’s an ‘ain’t what’s paid’ price.” (03:02)

• Systemic Consequences:
  • Even if your copay is low, you’re still paying for high drug prices indirectly through raised premiums and taxes (04:12).
  • The system creates a false sense of savings by shifting costs:

    “...they want you to just look at the copay and not realize you’re paying vastly higher premiums than you should.” —Sharyl Attkisson (00:55)

2. The Role of Middlemen and Insurance

• Why So Many Intermediaries?

  • The drug’s journey: manufacturer → wholesaler → pharmacy → consumer, with additional roles for insurance and pharmacy benefit managers (PBMs) (05:05).
  • Some middlemen are necessary (e.g., pharmacists check for drug conflicts), but others exist purely for distribution and profit (05:05).
  • Hoadley notes,

    “We probably could cut out some of those additional middlemen.” (05:05)

• How Money Moves

  • Complex flow: Consumers, insurers, PBMs, and manufacturers all negotiate different prices and rebates which leads to confusion and price distortion.
  • Drug rebates: The manufacturer may set a high price knowing it will provide a large rebate back to the insurance plan, which distorts the actual cost (06:47):

    “The manufacturer sends them [$50] as a rebate, so the net price ends up being $50.” —Jack Hoadley (07:57)

3. GoodRx and Similar Discount Tools

• How GoodRx Works (09:06):

  • GoodRx negotiates with PBMs to offer discounts to individual consumers, acting like a mini-insurance plan—but for people who are uninsured or face high deductibles.
  • GoodRx profits by taking a “little bit of the discount back in their fees, but then they’re still giving you a better price than… off the street.” (10:40)

• Why GoodRx Can Beat Your Copay

  • Sometimes, the price you get through GoodRx is lower than through your insurance (12:31).

    “Maybe GoodRx does [get a better deal], and GoodRx tries to create deals with every manufacturer…” —Jack Hoadley (12:31)

  • This usually happens when the insurance plan hasn't negotiated well for a particular drug or when copays are high.

• On Starting a Discount Company

  • Yes, in theory, anyone could attempt to start such a company, but leverage with PBMs and scale are essential for negotiating discounts (10:58):

    “You can’t go in as an individual and say to that PBM, ‘Hey, I’m a customer. Can you give me the discount?’” (11:04)

4. Trump Rx: An Alternative Approach

• Different Negotiation Tactics (13:49):
  • Trump Rx tries to negotiate discounts based on international pricing, leveraging tariffs to pressure manufacturers into offering U.S. consumers prices closer to what Europeans pay.
  • While details remain vague, this is positioned as a direct-to-consumer program, especially helpful for the uninsured or those with high deductibles.

  • “Trump is using the leverage of tariffs… I’ll penalize you with a high tariff but get rid of that tariff if you give me the better price.” —Jack Hoadley (14:51)

5. Practical Advice for Consumers

• When to Use Insurance vs. Discounts

  • “In most cases, using the insurance is probably still going to be the best deal… many cases, with your insurance, there’s going to be at some point an out-of-pocket maximum” (16:29)
  • HOWEVER, for high-deductible plans or the uninsured, discount programs may offer better deals before you meet your deductible.

• Shopping Around

  • Always compare pharmacy prices, look at GoodRx, explore manufacturer assistance and copay programs, and ask about cheaper alternatives (19:21):

    “Shop different pharmacies… look at things like GoodRx… look at manufacturer assistance programs…” —Jack Hoadley (19:27)

  • Talk with your doctor about generic or alternative drugs.

Notable Quotes & Memorable Moments

• On “Dirty Little Secrets” of Drug Pricing:

  “Your insurance companies and drug companies conspire to inflate prices so that they can then give you fake discounts and look like they're saving you money when they're actually charging you more.” —Sharyl Attkisson (00:45)

• On the Illusion of Copays:

  “If you think your insurance is saving you a ton of money because you’re just paying a $5 or $35 copay, au contraire…” —Sharyl Attkisson (00:35)

• On Navigating the Mess:

  “For the first 20 years of my research career… I don't want to deal with drug issues… whether we’re talking about the FDA side or payment side… It's a level of complexity…” —Jack Hoadley (18:19)

• Practical Insight:

  “Doctors used to want nothing to do with the pricing side. Nowadays, most doctors understand drugs are often very expensive and they're well equipped… to help you figure out a cheaper way.” —Jack Hoadley (20:23)

• Final Reflection:

  “Still confused? After all, we're mere mortals. This is way above things most of us can easily understand.” —Sharyl Attkisson (21:00)

Key Timestamps for Important Segments

• 00:45 — Sharyl Attkisson exposes the collusion behind fake drug price discounts
• 02:08 — Jack Hoadley’s background and how he came to study drug pricing
• 03:02 — Why drug prices are artificial and misleading
• 06:47–09:06 — The pharmacy and insurance “money circle” and how rebates work
• 09:13 — What is GoodRx (and how it works for uninsured or high-deductible customers)
• 12:31 — Why GoodRx can sometimes offer lower prices than your insurance copay
• 13:57 — Discussion of Trump Rx and its international/pricing leverage strategy
• 16:29 — Advice on when (and whether) to use insurance vs. discount programs
• 19:21 — Shopping strategies: alternatives and assistance programs
• 20:23 — Encouragement to work with doctors and investigate all options

Conclusion & Takeaways

Drug pricing in America is intentionally complex and often misleading—even experts struggle to unravel all the forces at play. Consumers are encouraged to:

• Always check both their insurance and discount options like GoodRx or Trump Rx
• Shop at different pharmacies, seek out assistance programs, and talk frankly to their doctors about cost considerations
• Remember that even low copays can hide high societal and personal costs due to inflated premiums and taxes

The path to transparency and savings in drug pricing is challenging and demands persistent questioning and research—but the potential rewards for vigilant consumers can be significant.